Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope.
Wölfel C, Drexler I, Van Pel A, Thres T, Leister N, Herr W, Sutter G, Huber C, Wölfel T.
Wölfel C, et al. Among authors: wolfel t.
Int J Cancer. 2000 Nov 1;88(3):432-8.
Int J Cancer. 2000.
PMID: 11054673
Free article.
Two tyrosinase-derived peptides are presented in association with HLA-A2.1 [Wolfel et al., Eur. J. Immunol., 24, 759-764 (1994)]. Peptide 1-9 (MLLAVLYCL) is generated from the putative signal sequence. ...Cellular immune responses against this hydrophobic peptide can be mo …
Two tyrosinase-derived peptides are presented in association with HLA-A2.1 [Wolfel et al., Eur. J. Immunol., 24, 759-764 (1994)]. Pep …